Federalizing Medicaid

Here is a new post I’ve got up at the Health Care Cost Monitor, in which I try to convince folks that even Republicans should be in favor of federalizing Medicaid. I’d love your feedback, as I’m still developing this idea.

Here is a new post I’ve got up at the Health Care Cost Monitor, in which I try to convince folks that even Republicans should be in favor of federalizing Medicaid. I’d love your feedback, as I’m still developing this idea.
The Managing Editor of the New England Journal of Medicine interviewed me about the piece I wrote, with David Comerford and Eric Johnson, on redesigning the health insurance exchanges. For those of you with long commutes, here is that podcast: Healthcare.gov 3.0
Recently, I wrote an Op-Ed in the New York Timescalling upon physicians to discuss out-of-pocket costs with their patients before making medical decisions, and urging patients to take matters into their own hands if their physicians fail to initiate such conversations. This Op-Ed closely mirrored an argument I made in the New England Journal of Medicine with my colleagues Yousuf Zafar and Amy…
Until recently, hospitals in California had little reason to reduce the fees they charged for procedures like knee and hip replacement. Insurance companies might come their way, trying hard to bargain down their rates. But the hospitals knew that if enough of them said “no” to these lower fees, insurance companies would be left with…
It is always important to remember that healthcare and health insurance are two very different things, and neither of them is a guarantee of good health. Therefore, when people talk about Obamacare providing people with medical care, we have to remember that it primarily provides people with health care insurance. And as I have written about previously, insurance coverage…
Despite Barack Obama’s recent surge in the polls, much could change between now and election day. While it looks like this election will be decided by the economy, unexpected events could dramatically change the campaign narrative. Terrorists could conduct an attack inside the US. Obama, despite his two years of steady poise, could say something…
For years now, the pharmaceutical industry has justified its prices and its profits by reminding us that their products eventually go off patent, and are then offered cheaply to people around the world in generic form. They warned us that the pipeline for new and innovative drugs is less and less promising, because so many…